Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH
NCT: NCT07166172 · RECRUITING
Brief Summary
This registry study aims to confirm that FETO increases neonatal survival to discharge and reduces long-term morbidity in fetuses with isolated left CDH and o/e LHR \< 30%, or isolated right CDH and o/e LHR ≤ 45%, compared to those receiving standard care. This prospective registry plans to enroll 80 pregnant women (40 treatment/40 control) with fetuses diagnosed with isolated CDH, and the children will be followed for up to 24 months.
Frequently Asked Questions
What is Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH?
Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH is a clinical trial registered under NCT07166172. Current status: RECRUITING.
What is the status of NCT07166172?
The current status of NCT07166172 (Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH) is: RECRUITING.
When did Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH start?
Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH started on 2025-06-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.